- Home>
- Journal Watch
- >
- Hepatitis B Surface Antigen
Search for Hepatitis B Surface Antigen in all Journal Watch editions
Physician-authored summaries on the latest research on Hepatitis B Surface Antigen, editorials on Hepatitis B Surface Antigen, and perspectives on Hepatitis B Surface Antigen - drawn from the top medical journals.
Sort by:
Items 1 to 20 of 83 results - Relevance
- Date
You searched for: Hepatitis B Surface Antigen
-
High Hepatitis B Surface Antigen Level Increases Risk for Hepatocellular Carcinoma
- May 4, 2012
- Atif Zaman, MD, MPH
- Gastroenterology
The finding was for patients with a low hepatitis B virus DNA level.- Reviewing:
- Tseng T-C et al., Gastroenterology 2012 May; 142:1140.
-
Hepatocellular Carcinoma and Hepatitis B Surface Antigen Seroclearance
- September 25, 2009
- Atif Zaman, MD, MPH
- Gastroenterology
After achieving HBsAg seroclearance, HBV patients are at risk for HCC.- Reviewing:
- Tong MJ et al., Clin Gastroenterol Hepatol 2009 Aug; 7:889.
-
Transmission of Hepatitis B Virus from Blood Donors with Occult Infection? Free
- March 23, 2011
- Neil M. Ampel, MD
- Infectious Diseases
Occult HBV infection was uncommon among blood donors in Hong Kong, and HBV transmission from donors with such infection was relatively rare.- Reviewing:
- Yuen M-F et al., Clin Infect Dis 2011 Mar 1; 52:624.
-
Hepatitis B Virus Infection and Non-Hodgkin Lymphoma
- August 17, 2010
- Michael E. Williams, MD
- Oncology and Hematology
Risk for NHL was associated with hepatitis B surface antigen positivity.- Reviewing:
- Engels EA et al., Lancet Oncol 2010 Aug 4;:
-
Hepatitis B and HIV — A Tale of Two Viruses
- July 6, 2009
- Charles B. Hicks, MD
- HIV/AIDS
In HIV-infected women with isolated antibody to hepatitis B core antigen, use of ART was associated with acquisition of antibody to hepatitis B surface antigen.- Reviewing:
- French AL et al., Clin Infect Dis 2009 Jul 1; 49:148.
-
Hepatitis B: Identification and Management
- October 8, 2008
- Stephen G. Baum, MD
- Infectious Diseases
An update and synthesis of previous hepatitis B guidelines, expanding at-risk groups and medical treatment options- Reviewing:
- Centers for Disease Control and Prevention (CDC)., MMWR Recomm Rep 2008 Sep 19; 57:1.
-
Occult HBV Infection in HIV/HCV-Coinfected Patients
- November 9, 2007
- Rajesh T. Gandhi, MD
- HIV/AIDS
Although HBV DNA is frequently found in the liver of HIV/HCV-coinfected patients, the clinical implication of this finding is uncertain.- Reviewing:
- Raffa G et al., AIDS 2007 Oct; 21:2171.
-
Breast-feeding 2005
- March 28, 2005
- Howard Bauchner, MD
- Pediatrics and Adolescent Medicine
Highlights from the AAP's policy statement- Reviewing:
- Gartner LM et al., Pediatrics 2005 Feb; 115:496-506.
-
Predicting Response to Hepatitis B Virus Therapy
- August 7, 2009
- Atif Zaman, MD, MPH
- Gastroenterology
Hepatitis B virus surface antigen levels during and after pegylated interferon alfa-2a therapy might be predictors of sustained virologic response.
CME Exam- Reviewing:
- Moucari R et al., Hepatology 2009 Apr; 49:1151. Brunetto MR et al., Hepatology 2009 Apr; 49:1141.
-
Lamivudine Is Ineffective for Treating Acute HBV Infection
- April 27, 2007
- Atif Zaman, MD, MPH
- Gastroenterology
Lamivudine reduced HBV DNA levels but did not improve clinical outcomes in a randomized, placebo-controlled trial in India.- Reviewing:
- Kumar M et al., Hepatology 2007 Jan; 45:97-101.
-
Preventing Mother-to-Child Transmission of HBV
- May 9, 2006
- Atif Zaman, MD, MPH
- Gastroenterology
Administering hepatitis B vaccine, HBIG, or both to newborn infants significantly reduces HBV transmission from HBsAg-positive mothers.- Reviewing:
- Lee C et al., BMJ 2006 Feb 11; 332:328-36.
-
MOST ASYMPTOMATIC HBsAg CARRIERS HAVE A GOOD PROGNOSIS.
- February 9, 1993
- ASB
- General Medicine
Blood donor screening occasionally identifies asymptomatic carriers of hepatitis B surface antigen (HBsAg). This study from Italy followed 92 such carriers to determine their long-term . . .- Reviewing:
- de Franchis R et al., Ann Intern Med 1992 Feb 1; 118:
191 194 .
-
PREVALENCE OF HIV ANTIBODY IN LABORATORY SPECIMENS.
- December 25, 1987
- THL
- General Medicine
Chilling data for health care workers have been reported from an urban teaching hospital in Seattle. Investigators tested the prevalence of hepatitis B surface antigen . . .- Reviewing:
- Handsfield H H; Cummings M J; Swenson P D., JAMA 1987 Dec 18; 258:
3395 3397 .
-
Response to Interferon-Based Therapy in HBV Varies by IL28B Polymorphisms
- March 30, 2012
- Atif Zaman, MD, MPH
- Gastroenterology
More evidence that host factors matter in the pursuit of successful antiviral therapy- Reviewing:
- Sonneveld MJ et al., Gastroenterology 2012 Mar; 142:513.
-
Entecavir Protects Against Recurrent HBV Infection After Liver Transplantation
- December 9, 2011
- Atif Zaman, MD, MPH
- Gastroenterology
No episodes of hepatitis B virus flares or graft loss caused by recurrent infection were observed.
CME Exam- Reviewing:
- Fung J et al., Gastroenterology 2011 Oct; 141:1212.
-
Hepatitis B in the U.S., 1999–2008
- March 2, 2011
- Stephen G. Baum, MD
- Infectious Diseases
The rates of HBV exposure and chronic infection were significantly lower in 1999–2008 than in 1988–1994; 2-year-olds had higher immunity rates than adults.- Reviewing:
- Ioannou GN., Ann Intern Med 2011 Mar 1; 154:319.
-
Tenofovir for HIV and Hepatitis B Virus Coinfection
- February 18, 2011
- Atif Zaman, MD, MPH
- Gastroenterology
Long-term use of tenofovir as part of antiretroviral therapy was safe and effective in reducing HBV DNA levels.
CME Exam- Reviewing:
- de Vries-Sluijs TEMS et al., Gastroenterology 2010 Dec; 139:1934.
-
Not So Fast: Hepatitis B Vaccination in HIV-Infected Patients
- February 14, 2011
- Rajesh T. Gandhi, MD
- HIV/AIDS
An accelerated vaccination schedule improves compliance but sacrifices efficacy in those with CD4 counts <500 cells/mm3.- Reviewing:
- de Vries-Sluijs TEMS et al., J Infect Dis 2011 Jan 25;:
-
Peginterferon, Adefovir, or Both for Chronic Hepatitis Delta Virus Infection
- February 4, 2011
- Atif Zaman, MD, MPH
- Gastroenterology
A 48-week regimen of peginterferon alfa-2a achieved HDV RNA clearance in more than 25% of patients, whereas adefovir had no effect.- Reviewing:
- Wedemeyer H et al., N Engl J Med 2011 Jan 27; 364:322.
-
Hepatitis B Virus Reactivation After Rituximab Therapy
- November 2, 2010
- Michael E. Williams, MD
- Oncology and Hematology
Reactivation occurred in 12% of lymphoma patients who were seropositive for prior HBV infection.- Reviewing:
- Niitsu N et al., J Clin Oncol 2010 Sep 13;:
Sort by:
Items 1 to 20 of 83 results - Relevance
- Date
